Literature DB >> 15831478

Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Carol Imbriano1, Aymone Gurtner, Fabienne Cocchiarella, Silvia Di Agostino, Valentina Basile, Monica Gostissa, Matthias Dobbelstein, Giannino Del Sal, Giulia Piaggio, Roberto Mantovani.   

Abstract

In response to DNA damage, p53 activates G(1)/S blocking and apoptotic genes through sequence-specific binding. p53 also represses genes with no target site, such as those for Cdc2 and cyclin B, key regulators of the G(2)/M transition. Like most G(2)/M promoters, they rely on multiple CCAAT boxes activated by NF-Y, whose binding to DNA is temporally regulated during the cell cycle. NF-Y associates with p53 in vitro and in vivo through the alphaC helix of NF-YC (a subunit of NF-Y) and a region close to the tetramerization domain of p53. Chromatin immunoprecipitation experiments indicated that p53 is associated with cyclin B2, CDC25C, and Cdc2 promoters in vivo before and after DNA damage, requiring DNA-bound NF-Y. Following DNA damage, p53 is rapidly acetylated at K320 and K373 to K382, histones are deacetylated, and the release of PCAF and p300 correlates with the recruitment of histone deacetylases (HDACs)-HDAC1 before HDAC4 and HDAC5-and promoter repression. HDAC recruitment requires intact NF-Y binding sites. In transfection assays, PCAF represses cyclin B2, and a nonacetylated p53 mutant shows a complete loss of repression potential, despite its abilities to bind NF-Y and to be recruited on G(2)/M promoters. These data (i) detail a strategy of direct p53 repression through associations with multiple NF-Y trimers that is independent of sequence-specific binding of p53 and that requires C-terminal acetylation, (ii) suggest that p53 is a DNA damage sentinel of the G(2)/M transition, and (iii) delineate a new role for PCAF in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831478      PMCID: PMC1084283          DOI: 10.1128/MCB.25.9.3737-3751.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor.

Authors:  J Yun; H D Chae; H E Choy; J Chung; H S Yoo; M H Han; D Y Shin
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

2.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  The PCAF acetylase complex as a potential tumor suppressor.

Authors:  R L Schiltz; Y Nakatani
Journal:  Biochim Biophys Acta       Date:  2000-03-27

4.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

5.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development.

Authors:  R A Currie
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

7.  p53 regulates a G2 checkpoint through cyclin B1.

Authors:  S A Innocente; J L Abrahamson; J P Cogswell; J M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Mechanisms of G2 arrest in response to overexpression of p53.

Authors:  W R Taylor; S E DePrimo; A Agarwal; M L Agarwal; A H Schönthal; K S Katula; G R Stark
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

9.  The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated.

Authors:  F Bolognese; M Wasner; C L Dohna; A Gurtner; A Ronchi; H Muller; I Manni; J Mossner; G Piaggio; R Mantovani; K Engeland
Journal:  Oncogene       Date:  1999-03-11       Impact factor: 9.867

10.  Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex.

Authors:  A Farina; I Manni; G Fontemaggi; M Tiainen; C Cenciarelli; M Bellorini; R Mantovani; A Sacchi; G Piaggio
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

View more
  98 in total

1.  TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.

Authors:  Kang Liu; Shiyun Ling; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Multilevel support vector regression analysis to identify condition-specific regulatory networks.

Authors:  Li Chen; Jianhua Xuan; Rebecca B Riggins; Yue Wang; Eric P Hoffman; Robert Clarke
Journal:  Bioinformatics       Date:  2010-04-07       Impact factor: 6.937

3.  Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Authors:  Connie Chao; Zhiqun Wu; Sharlyn J Mazur; Helena Borges; Matteo Rossi; Tongxiang Lin; Jean Y J Wang; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.

Authors:  Lisa Osterloh; Björn von Eyss; Fabienne Schmit; Lena Rein; Denise Hübner; Birgit Samans; Stefanie Hauser; Stefan Gaubatz
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

5.  Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.

Authors:  Barbara Testoni; Christine Völlenkle; Francesca Guerrieri; Sabine Gerbal-Chaloin; Giovanni Blandino; Massimo Levrero
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

6.  NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.

Authors:  Philip Hublitz; Natalia Kunowska; Ulrich P Mayer; Judith M Müller; Kristina Heyne; Na Yin; Claudia Fritzsche; Cecilia Poli; Laurent Miguet; Ingo W Schupp; Leo A van Grunsven; Noëlle Potiers; Alain van Dorsselaer; Eric Metzger; Klaus Roemer; Roland Schüle
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

7.  The histone-like NF-Y is a bifunctional transcription factor.

Authors:  Michele Ceribelli; Diletta Dolfini; Daniele Merico; Raffaella Gatta; Alessandra M Viganò; Giulio Pavesi; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

Review 8.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

9.  Regulation of the p53 transcriptional response by structurally diverse core promoters.

Authors:  José M Morachis; Christopher M Murawsky; Beverly M Emerson
Journal:  Genes Dev       Date:  2009-12-29       Impact factor: 11.361

10.  Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.

Authors:  Luke Pett; Konstantinos Kiakos; Vijay Satam; Pravin Patil; Sarah Laughlin-Toth; Matthew Gregory; Michael Bowerman; Kevin Olson; Mia Savagian; Megan Lee; Moses Lee; W David Wilson; Daniel Hochhauser; John A Hartley
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-10-24       Impact factor: 4.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.